NCT04087876 2025-04-06Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic AlterationsBasilea PharmaceuticaNo longer available
NCT03414489 2025-03-18Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)RedHill Biopharma LimitedNo longer available